Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Community health worker-led intervention to reduce hypertension in Black churches

Official title: Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities

Run by Tulane University · NCT06133322 · Data updated 2026-11-12

This study is testing whether a program led by community health workers in Black churches can help people with high blood pressure improve their health better than regular care.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1176 (estimated)
SponsorTulane University
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (New Orleans, Louisiana)
StatusRecruiting
StartedNovember 1, 2023
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedOctober 1, 2026
Trial IDNCT06133322 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include Black adults aged 18 and older with hypertension who are associated with participating churches.

Probably not a fit

Patients with recent hospitalizations for heart failure or heart attacks, current cancer treatment, or severe chronic kidney disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The BLESSED trial aims to address the high rates of hypertension and related cardiovascular diseases in Black populations by implementing a community health worker (CHW)-led multifaceted intervention in predominantly Black churches. This cluster randomized trial will recruit 1,176 adults with hypertension from 42 churches in the Greater New Orleans area and compare the effectiveness of the CHW-led strategy against enhanced usual care over an 18-month period. The study will also evaluate various implementation outcomes, including acceptability and sustainability, using the Exploration, Preparation, Implementation, Sustainment (EPIS) framework. Participants will receive health coaching, lifestyle change support, and access to community-based healthcare resources.

Why it matters

Potential benefit: If successful, this intervention could significantly lower blood pressure and reduce cardiovascular disease risk among Black community members.

How similar studies have gone: Other studies have shown success with community-based interventions targeting hypertension in similar populations, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Men or women aged ≥18 years
2. Community members associated with the participating churches (church members and their families and friends)
3. Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mm Hg
4. Willing and able to participate in the intervention.
5. Willing and able to sign written informed consent.

Exclusion Criteria:

1. Prior hospitalization in the last 3 months for chronic heart failure or heart attack
2. Current diagnosis of cancer requiring chemotherapy or radiation therapy
3. Stage-5 chronic kidney disease requiring chronic dialysis or transplant
4. Pregnant or planning to become pregnant in the next 18 months
5. Planning to move out of the Greater New Orleans area during the next year

Where it's running

  • Tulane University
    New Orleans, Louisiana, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.